Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search



Kumlesh Dev
Professor, Physiology
Professor, Trinity Inst. of Neurosciences (TCIN)

Publications and Further Research Outputs

Peer-Reviewed Publications

Dev K.K, Irving A.J, Lipid sensing G protein-coupled receptors in the CNS, Neuropharmacology, 113, 2017, p595 - 596 Journal Article, 2017 URL DOI

O'Sullivan S.A, Velasco-Estevez M, Dev K.K, Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors, GLIA, 2017, p23148- Journal Article, 2017 DOI URL

O'Sullivan S, Dev K.K, Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases, Neuropharmacology, 113, 2017, p597 - 607 Journal Article, 2017 DOI URL

Madill M, Fitzgerald D, O'Connell K.E, Dev K.K, Shen S, FitzGerald U, In vitro and ex vivo models of multiple sclerosis, Drug Discovery Today, 21, (9), 2016, p1504 - 1511 Journal Article, 2016 URL DOI

Dev K.K, Common receptor signalling in glial & immune cells, Current Drug Targets, 17, (16), 2016, p1828- Journal Article, 2016 URL

O'Sullivan C, Schubart A, Mir A.K, Dev K.K, The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures, Journal of Neuroinflammation, 13, (1), 2016, p31- Journal Article, 2016 TARA - Full Text DOI URL

O'Sullivan S.A, Gasparini F, Mir A.K, Dev K.K, Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes, Journal of Neuroinflammation, 13, (1), 2016, p189- Journal Article, 2016 URL TARA - Full Text DOI

Rutkowska A, O'Sullivan S.A, Christen I, Zhang J, Sailer A.W, Dev K.K, The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages, Scientific Reports, 6, 2016, p25520 - Journal Article, 2016 TARA - Full Text DOI URL

O'Sullivan C, Dev K.K, Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling, Journal of Cell Science, 128, (21), 2015, p3878 - 3887 Journal Article, 2015 DOI URL

Rutkowska, A. Preuss, I. Gessier, F. Sailer, A.W. Dev, K.K., EBI2 regulates intracellular signaling and migration in human astrocyte, Glia, 63, (2), 2015, p341 - 351 Journal Article, 2015 URL DOI

Elain, G, Jeanneau, K, Rutkowska, A, Mir, AK, Dev, KK, The Selective Anti-IL17A Monoclonal Antibody Secukinumab ( AIN457) Attenuates IL17A-Induced Levels of IL6 in Human Astrocytes, GLIA, 62, (5), 2014, p725-735 Journal Article, 2014 DOI

O'Connell, K.E., Frei, P. , Dev, K.K., The premium of a big pharma license deal, 2014, - 617-619 Miscellaneous, 2014 DOI

Muirhead, G. Dev, K.K., The expression of neuronal sorting nexin 8 (SNX8) exacerbates abnormal cholesterol levels, Journal of Molecular Neuroscience, 53, (1), 2014, p125 - 134 Journal Article, 2014 DOI URL

Elain, G. Jeanneau, K. Rutkowska, A. Mir, A.K. Dev, K.K., The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes, Glia, 62, (5), 2014, p725 - 735 Journal Article, 2014 DOI URL

Pritchard, AJ, Mir, AK, Dev, KK, Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures, PLOS ONE, 9, (6), 2014, p0099444- Journal Article, 2014 DOI TARA - Full Text

Muirhead, G, Dev, KK, The Expression of Neuronal Sorting Nexin 8 (SNX8) Exacerbates Abnormal Cholesterol Levels, JOURNAL OF MOLECULAR NEUROSCIENCE, 53, (1), 2014, p125-134 Journal Article, 2014 DOI

O'Connell, K.E. Thakore, J. Dev, K.K., Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication, Cytokine, 73, (1), 2014, p196-198 Journal Article, 2014 URL DOI

Sheridan, GK, Dev, KK, Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations, SCIENTIFIC REPORTS, 4, 2014, p5051- Journal Article, 2014 TARA - Full Text DOI

Dutta, P., O'Connell, K.E., Ozkan, S.B., Sailer, A.W., Dev, K.K., The protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell deat, Journal of Neurochemistry, 130, (3), 2014, p360-373 Journal Article, 2014 TARA - Full Text DOI

Frei, P., Dev, K.K., Drug dealers: $20 trillion of in-licensing payments (Editorial), Drug Discovery Today, 18, (21-22), 2014, p1027-1029 Journal Article, 2014 DOI

O'connell, K.E. Mok, T. Sweeney, B. Ryan, A.M. Dev, K.K., The use of cytokine signature patterns: Separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients, Autoimmunity, 47, (8), 2014, p505 - 511 Journal Article, 2014 URL DOI

Shrestha, R., Millington, O., Brewer, J., Dev, K.K., Bushell, T.J., Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways, Neuropharmacology, 76, (a), 2014, p184-193 Journal Article, 2014 DOI

O'Connell, KE, Thakore, J, Dev, KK, Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine, SCHIZOPHRENIA RESEARCH, 156, (1), 2014, p1-8 Journal Article, 2014 DOI

Healy LM, Sheridan GK, Pritchard AJ, Rutkowska A, Mullershausen F, Dev KK, Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes., British journal of pharmacology, 169, (5), 2013, p1114-1129 Journal Article, 2013 TARA - Full Text DOI

Pritchard, A.J., Dev, K.K. , The role of sphingosine 1-phosphate receptors in the treatment of demyelinating diseases (Review), Future Neurology, 8, (5), 2013, p569-581 Journal Article, 2013 DOI

O'Connell K, Thakore J, Dev KK, Levels of S100B are raised in female patients with schizophrenia., BMC psychiatry, 13, 2013, p146 Journal Article, 2013 DOI TARA - Full Text

O'Sullivan, C., Dev, K.K. , The structure and function of the S1P1 receptor (Review), Trends in Pharmacological Sciences, 34, (7), 2013, p401-412 Journal Article, 2013 DOI

Doucet MV, Levine H, Dev KK, Harkin A, Small-Molecule Inhibitors at the PSD-95/nNOS Interface have Antidepressant-Like Properties in Mice., Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38, (8), 2013, p1575-1584 Journal Article, 2013 DOI

A. Bolia, Z.N. Gerek, O. Keskin, S.B. Ozkan, K.K. Dev, Computational analysis of PICK1 PDZ domain binding affinities, Proteins: Structure, Function, and Bioinformatics Journal, 2012 Journal Article, 2012

G.K. Sheridan, K.K. Dev, The S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures., Glia, 60, 2012, p382 - 392 Journal Article, 2012

Doucet MV, Harkin A, Dev KK, The PSD-95/nNOS Complex: New Drugs for Depression?, Pharmacology & Therapeutics, 133, 2012, p218 - 229 Journal Article, 2012 TARA - Full Text

Doucet MV, Harkin A, Dev KK, The PSD-95/nNOS complex: New drugs for depression?, Pharmacology and Therapeutics, 133, (2), 2012, p218-29 Journal Article, 2012 DOI

Bolia A, Gerek ZN, Keskin O, Banu Ozkan S, Dev KK, The binding affinities of proteins interacting with the PDZ domain of PICK1., Proteins, 80, (5), 2012, p1393-408 Journal Article, 2012

Sheridan GK, Dev KK, S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures., Glia, 60, (3), 2012, p382-92 Journal Article, 2012

Claus Rieker, Kumlesh K. Dev, Katja Lehnhoff, Samuel Barbieri, Iwona Ksiazek, Sabine Kauffmann, Simone Danner, Heinrich Schell, Cindy Boden, Markus A. Ruegg, Philipp J. Kahle, Herman van der Putten, Derya R. Shimshek, Neuropathology in Mice Expressing Mouse Alpha-Synuclein, PLoS ONE, 6, (9, e24834), 2011 Journal Article, 2011 TARA - Full Text

P. Dutta, D. Deb, L. Dargahi, D. Ivankovic, K.K. Dev, The GPR37/PAEL Receptor - Finding a Way to the Cell Surface., Drug Discovery , 7, 2010, p36 - 39 Journal Article, 2010

H. Mattes, K.K. Dev, R. Bouhelal, C. Barske, F. Gasparini, D. Guerini, A.K. Mir, D. Orain, M. Osinde, A. Picard, C. Dubois, E. Tasdelen, S. Haessig. , Design and synthesis of selective and potent orally active S1P5 agonists., Chem Med Chem , 5, 2010, p1693 - 1696 Journal Article, 2010

S. Chatterjee, J.D. Szustakowski, N.R. Nanguneri, C. Mickanin, M.A. Labow, A. Nohturfft, K.K. Dev* and R. Sivasankaran. , Identification of Novel Genes and Pathways Regulating SREBP Transcriptional Activity. , PLoS ONE , 4, 2009, p5197- Journal Article, 2009 TARA - Full Text

Senechal Y, Prut L, Kelly PH, Staufenbiel M, Natt F, Hoyer D, Wiessner C, Dev KK, Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA., Brain research, 1243, 2008, p124-33 Journal Article, 2008

Osinde M, Clavaguera F, May-Nass R, Tolnay M, Dev KK, Lentivirus Tau (P301S) expression in adult amyloid precursor protein (APP)-transgenic mice leads to tangle formation., Neuropathology and applied neurobiology, 34, (5), 2008, p523-31 Journal Article, 2008

Olson BL, Hock MB, Ekholm-Reed S, Wohlschlegel JA, Dev KK, Kralli A, Reed SI, SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis., Genes & development, 22, (2), 2008, p252-64 Journal Article, 2008 DOI TARA - Full Text

M. Osinde, F. Clavaguera, R. May-Nass, M. Tolnay, and K.K. Dev. , Lentivirus Tau (P301S) expression in adult amyloid precursor protein (APP)-transgenic mice leads to tangle formation. , Neuropath Applied Neurobiol,, 34, 2008, p523 - 531 Journal Article, 2008

H. Mattes, J. Nozulak, D. Orain, K.K. Dev., Phthalazine and Isoquinoline derivatives with S1P receptor modulating activities., 2008, International Application No. PCT/EP2008/054797. Pub. No. WO/2008/129029 Patent, 2008

Y. Senechal, P.H. Kelly, and K.K Dev. , APP knockout mice show age-dependent deficits in passive avoidance learning. , Behav Brian Res, 186, 2008, p126 - 132 Journal Article, 2008

H. Mattes, J. Nozulak, D. Orain, K.K. Dev., Benzamides useful as S1P receptor modulators, 2008, International Application No. PCT/EP2008/056175. Pub No. WO/2008/142073 Patent, 2008

K.K. Dev, F. Mullershausen, H. Mattes, R. Kuhn, G. Bilbe, D. Hoyer, A. Mir, Brain S1P receptors: implication for fingolimod in the treatment of multiple sclerosis., Pharmacology & Therapeutics , 117, 2008, p77 - 93 Journal Article, 2008

B.L. Olson, M.B. Hock, S. Ekholm-Reed, J.A. Wohlschlegel, K.K. Dev, A. Kralli, and S.I. Reed. , SCFCdc4 acts antagonistically to the PGC-1{alpha} transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. , Genes Development , 22, 2008, p252 - 264 Journal Article, 2008

Y. Senechal, L. Prut, M. Staufenbiel, F. Natt, D. Hoyer, C. Wiessner, and K.K Dev., siRNA-mediated knockdown of APP reverses locomotor hyperactivity in the APP23 mouse model of Alzheimer's Disease., Brain Research , 1243, 2008, p124 - 133 Journal Article, 2008

Senechal Y, Kelly PH, Dev KK, Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning., Behavioural brain research, 186, (1), 2008, p126-32 Journal Article, 2008

S. Chatterjee, R. Sivasankaran, R. Kuhn and K.K. Dev., Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases , 2007, International Application No. PCT/EP2007/055726. Pub. No. WO/2007/141346 Patent, 2007

K.K. Dev, PDZ domain protein-protein interactions: a case study with PICK1, Current Topics in Medicinal Chemistry , 7, 2007, p3 - 20 Journal Article, 2007

F. Mullershausen, L.M. Craveiro, Y. Shin, M. Cortes-Cros, F. Bassilana, M. Osinde, W.L. Wishart, D. Guerini, M. Thallmair, M.E. Schwab, R. Sivasankaran, K. Seuwen and K.K. Dev. , Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors., J. Neurochemistry , 102, 2007, p1151 - 1161 Journal Article, 2007

Y. Senechal, P.H. Kelly, J.F. Cryan, F. Natt, and K.K Dev., Amyloid precursor protein knockdown by siRNA impairs spontaneous alternation in adult mice. , J. Neurochemistry , 102, 2007, p1928 - 1940 Journal Article, 2007

M. Osinde, F. Mullershausen and K.K. Dev. , Phosphorylated FTY720 stimulates ERK phosphorylation in Astrocytes via S1P receptors. Neuropharmacology, 52, 2007, p1210 - 1218 Journal Article, 2007

J.F. Cryan and K.K. Dev, The Glutamatergic System as a Potential Therapeutic Target for the Treatment of Anxiety Disorders, PUBLISHED BOOK Handbook of Anxiety and Fear, Elsevier, Academic Press , 17, 2007, p269 - 301 Journal Article, 2007

Y. Senechal, Y. Larmet and K.K. Dev, Unraveling in vivo functions of Amyloid Precursor Protein: insights from knockout and knockdown studies, Neurodegenerative Diseases , 3, 2006, p134 - 147 Journal Article, 2006

K.K. Dev, Using RNAi in the Clinic, Investigational Drugs Journal , 9, 2006, p279 - 282 Journal Article, 2006

K.K. Dev and J.M. Henley, The Schizophrenic Faces of PICK1, Trends Pharmacol Sci , 27, 2006, p574 - 579 Journal Article, 2006 TARA - Full Text DOI

D. Hoyer and K. K. Dev, RNA interference as a therapeutic strategy for treating CNS disorders, Drug Discovery Today Therapeutic Strategies, 3, 2006, p451 - 456 Journal Article, 2006

K.K. Dev, S. Chatterjee, M. Osinde, D. Stauffer, H. Morgan, M. Kobialko, U. Dengler, H. Rueeger, B. Martoglio and G. Rovelli, Signal peptide peptidase dependent cleavage of type II transmembrane substrates releases intracellular and extracellular signals, Eur. J. Pharmacology , 540, 2006, p10 - 17 Journal Article, 2006

K.L. Madsen, T. Beuming, M.Y. Niv, C-W. Chang, K.K. Dev, H. Weinstein and U. Gether, Delineating the complex PDZ domain binding specificity of PICK1, J. Biol Chem , 280, 2005, p20539 - 20548 Journal Article, 2005

C. Mahé, E. Loetscher, K.K. Dev, I. Bobirnac, U. Otten and P. Schoeffter., Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells, Neuropharmacology, 49, 2005, p40 - 47 Journal Article, 2005

E. Friedmann, M.K. Lemberg, A. Weihofen, K.K. Dev, U. Dengler, G. Rovelli and B. Martoglio, Consensus analysis of Signal Peptide Peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared to Presenilins, J. Biol Chem , 279, 2004, p50790 - 50798 Journal Article, 2004

A. Terashima, L. Cotton, K.K. Dev, G. Meyer, S. Zaman, F. Duprat, J.M. Henley, G.L. Collingridge and J.T.R. Isaac, Regulation of synaptic strength & AMPA receptor subunit composition by PICK1, J. Neuroscience , 24, 2004, p5381 - 5390 Journal Article, 2004

K.K. Dev, Making protein interactions druggable: targeting PDZ domains, Nature Reviews Drug Discovery , 3, 2004, p1047 - 1056 Journal Article, 2004

C. Mahé, M. Bernhard, I. Bobirnac, C. Keser, E. Loetscher, D. Feuerbach, K.K. Dev and P. Schoeffter, Functional expression of serotonin 5-HT7 receptor in human glioblastoma cell lines, Br. J. Pharmacolology, 143, 2004, p404 - 410 Journal Article, 2004

K.K. Dev, S. Nakanishi and J.M. Henley, The PDZ domain of PICK1 differentially accepts Protein Kinase C-á and GluR2 as interacting ligands, J. Biol Chem , 279, 2004, p41393 - 41397 Journal Article, 2004

K.K. Dev, K. Hofele, S. Barbieri, V. Buchman and H. van der Putten. , Part II: á-Synuclein and its molecular pathophysiological role in neurodegenerative disease, Neuropharmacology, 45, 2003, p14 - 44 Journal Article, 2003

K. Cho, J. Francis, H. Hirbec, K. Dev, M. Brown, J. Henley, and Z. I. Bashir, Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptors, J. Physiology , 548, 2003, p723 - 730 Journal Article, 2003

H. Hirbec, J.C. Francis, S.E. Lauri, S.P. Braithwaite, F. Coussen, C. Mulle, K.K. Dev, V. Couthino, G. Meyer, J.T.R. Isaac, G.L. Collingridge and J.M. Henley, Rapid and differential regulation of AMPA and kainite receptors at hippocampal mossy fibre synapses by PICK1 and GRIP, Neuron , 37, 2003, p625 - 638 Journal Article, 2003

K.K. Dev, H. van der Putten, B. Sommer and G. Rovelli, Part I: Parkin-associated proteins and Parkinson's Disease, Neuropharmacology, 45, 2003, p1 - 13 Journal Article, 2003

N. Finney, F. Walther, P-Y. Mantel, D. Stauffer, G. Rovelli and K.K. Dev., The cellular protein level of Parkin is regulated by its ubiquitin-like domain, J. Biol Chem, 278, 2003, p16054 - 16058 Journal Article, 2003

H. Hirbec, O. Perestenko, A. Nishimune, G. Meyer, S. Nakanishi, J.M. Henley, and K.K. Dev, The PDZ Proteins PICK1, GRIP and Syntenin bind multiple glutamate receptor subtypes, J. Biol Chem , 277, 2002, p15221 - 15224 Journal Article, 2002

K.K. Dev, S. Nakanishi and J. M. Henley, Regulation of mGlu7 receptors by proteins that interact with the intracellular C-terminus, Trends Pharmacol Sci , 22, 2001, p355 - 361 Journal Article, 2001

E. Vernon, G. Meyer, L. Pickard, K. Dev, E. Molnar, G.L. Collingridge and J.M. Henley, GABAB receptors couple directly to the transcription factor ATF4, Molecular Cell Neuroscience , 17, 2001, p637 - 645 Journal Article, 2001

M.I. Daw, R. Chittajallu, Z.A. Bortolotto, K.K. Dev, F. Duprat, J.M. Henley, G.L. Collingridge and J.T.R. Isaac, PDZ Proteins interacting with c-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses, Neuron , 28, 2000, p873 - 886 Journal Article, 2000

K.K. Dev, Y. Nakajima, J. Kitano, S. P. Braithwaite, J. M. Henley and S. Nakanishi, PICK1 interacts with and regulates PKC phosphorylation of mGluR7, J. Neuroscience , 20, 2000, p7252 - 7257 Journal Article, 2000

M.J. Keir, M.J. Barakat, K.K. Dev, H. Bittiger, B. Bettler and J.M. Henley, Characterisation of GABAB receptor from rat cerebellum using novel antagonist [3H]CGP 62349, Molecular Brain Research , 71, 1999, p279 - 289 Journal Article, 1999

K.K. Dev, A. Nishimune, J.M. Henley and S. Nakanishi, The protein kinase Cá binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits, Neuropharmacology, 38, 1999, p635 - 644 Journal Article, 1999

K.K. Dev and J.M. Henley, The Regulation of AMPA receptor binding sites, Molecular Neurobiology , 17, 1998, p33 - 58 Journal Article, 1998

K.K. Dev, T. Honoré and J.M. Henley, Different effects of Phospholipase A2 on agonist binding to hippocampal, cortical and recombinant homomeric AMPA receptors, Neuroscience Letters , 246, 1998, p25 - 28 Journal Article, 1998

K.K. Dev, C. Foged, H. Andersen, T. Honoré and J.M. Henley, High affinity binding sites for [125I]-labelled pancreatic secretory phospholipase A2 in rat brain, Molecular Brain Research , 49, 1997, p120 - 126 Journal Article, 1997

K.K. Dev, V. Petersen, T. Honoré and J.M. Henley, Pharmacology and regional distribution of [3H] 6-nitro-7-sulphamoylbenzo(F)quinoxaline-2-3 dione ([3H]NBQX) binding to rat brain, J. Neurochemistry , 67, 1996, p2609 - 2612 Journal Article, 1996

R. Chittajallu, M. Vignes, K.K. Dev, J.M. Barnes, G.L. Collingridge and J.M. Henley, Regulation of glutamate release by presynaptic kainate receptors in the hippocampus, Nature, 379, 1996, p78 - 81 Journal Article, 1996

K.K. Dev, P.J. Roberts, and J.M. Henley, Characterisation of the interaction between guanyl nucleotides and AMPA receptors in rat brain, Neuropharmacology, 35, 1996, p1583 - 1593 Journal Article, 1996

K.K. Dev, T. Honoré and J.M. Henley, Phospholipase A2 down-regulates the affinity of [3H]AMPA binding to rat cortical membranes, J. Neurochemistry , 65, 1995, p184 - 191 Journal Article, 1995

J.M. Barnes, K. K. Dev and J. M. Henley, Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes, Br. J. Pharmacology , 113, 1994, p339 - 341 Journal Article, 1994 TARA - Full Text

K.K. Dev and B.J. Morris, Modulation of á-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites by nitric oxide, J. Neurochemistry , 63, 1994, p946 - 952 Journal Article, 1994

Research Expertise

Description

Research is based on investigating mechanisms that control receptor surface expression and thereby receptor function. With an interest in Multiple Sclerosis and Parkinson's Disease, we are investigating surface expression of receptors that are drug targets for these diseases, including sphingosine 1-phosphate receptors (S1P-R), parkin-associated endothelial like receptor (PAEL-R) and the interleukin 2 receptor (IL2-R). Our approach is to engineer, formulate and chemically re-design competitive blocking peptides and discover small molecular weight compounds, which alter receptor surface expression and function in vivo. Development of such agents permits cell-selective receptor modulation and the regulation of orphan receptors or difficult-to-target receptors. We are funded in kind and in part by Trinity College Dublin, Science Foundation Ireland, Health Research Board Ireland, Enterprise Ireland, The Wellcome Trust, Lundbeck, Actelion, Servier and Novartis.

Keywords

Drug Targets; Glutamate Receptors; Multiple Sclerosis; Neuroscience; Parkinson's Disease; Protein-Protein Interactions; Receptor Trafficking; Sphingosine 1-phosphate receptors

Recognition

Representations

Representative Director Ireland, Venture Valuation AG, Zurich, Switzerland

Memberships

Board Member of Journal of Biological Chemistry

Editorial Board Member of Canadian Journal of Pure and Applied Sciences